Pharmacokinetics and Effect on Type 2 Biomarker Levels of Dupilumab Weight Tiered-Based Dose Regimens in Patients Aged 6 to 11 Years with Uncontrolled, Moderate-to-Severe Asthma

Autor:	D.J. Jackson, L.B. Bacharier, L. Sher, C. Domingo Ribas, N. Papadopoulos, B.D. Modena, N. Li, C. Xia, S. Harel, K. Wolfe, M. Kamal, R. Gall, N. Amin, L. Mannent, E. Laws, P.J. Rowe, J.A. Jacob-Nara, Y. Deniz, D.J. Lederer, M.E. Hardin, C. Xu
Rok vydání:	2022
Zdroj:	C101. EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS.
DOI:	10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4846
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f2f237e6e4b5e4b4bcd9db26328f2ca3 https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4846 Zobrazit plný text záznamu